Healthcare provider profile · identity verified

Johanna Wang, MD

Internal Medicine · SHORELINE, WA · NPI 1043288764

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	205
Levothyroxine Sodium	Levothyroxine Sodium	292	87
Lisinopril	Lisinopril	283	88
Amlodipine Besylate	Amlodipine Besylate	274	87
Omeprazole	Omeprazole	248	78
Losartan Potassium	Losartan Potassium	233	80
Metoprolol Succinate	Metoprolol Succinate	176	55
Gabapentin	Gabapentin	167	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	150	27
Metformin Hcl	Metformin Hcl	143	50
Rosuvastatin Calcium	Rosuvastatin Calcium	136	50
Trazodone Hcl	Trazodone Hcl	136	39
Alendronate Sodium	Alendronate Sodium	122	40
Albuterol Sulfate Hfa	Albuterol Sulfate	114	45
Citalopram Hbr	Citalopram Hydrobromide	102	23
Pantoprazole Sodium	Pantoprazole Sodium	102	27
Tamsulosin Hcl	Tamsulosin Hcl	102	31
Potassium Chloride	Potassium Chloride	101	31
Metformin Hcl Er	Metformin Hcl	99	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	37
Clonazepam	Clonazepam	90	19
Simvastatin	Simvastatin	86	25
Zolpidem Tartrate	Zolpidem Tartrate	86	22
Sertraline Hcl	Sertraline Hcl	85	25
Atenolol	Atenolol	80	23
Estradiol	Estradiol	73	35
Hydrochlorothiazide	Hydrochlorothiazide	72	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	24
Furosemide	Furosemide	70	27
Venlafaxine Hcl Er	Venlafaxine Hcl	69	19
Alprazolam	Alprazolam	67	22
Escitalopram Oxalate	Escitalopram Oxalate	66	23
Spironolactone	Spironolactone	66	17
Bupropion Xl	Bupropion Hcl	65	17
Allopurinol	Allopurinol	61	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Acyclovir	Acyclovir	55	22
Duloxetine Hcl	Duloxetine Hcl	55	17
Fluticasone Propionate	Fluticasone Propionate	55	25
Tramadol Hcl	Tramadol Hcl	55	12
Eliquis	Apixaban	54	19
Pravastatin Sodium	Pravastatin Sodium	54	19
Clopidogrel	Clopidogrel Bisulfate	52	15
Lorazepam	Lorazepam	51	16
Jardiance	Empagliflozin	46	16
Baclofen	Baclofen	45	suppressed
Methocarbamol	Methocarbamol	45	15
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Buspirone Hcl	Buspirone Hcl	41	12
Tizanidine Hcl	Tizanidine Hcl	40	14
Famotidine	Famotidine	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	27
Diclofenac Sodium	Diclofenac Sodium	36	11
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Felodipine Er	Felodipine	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	13
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Fluconazole	Fluconazole	31	16
Topiramate	Topiramate	31	suppressed
Valsartan	Valsartan	31	suppressed
Prednisone	Prednisone	30	13
Ibuprofen	Ibuprofen	29	11
Ketoconazole	Ketoconazole	29	13
Carvedilol	Carvedilol	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Doxepin Hcl	Doxepin Hcl	27	12
Finasteride	Finasteride	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	11
Ondansetron Odt	Ondansetron	27	16
Trulicity	Dulaglutide	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Mirtazapine	Mirtazapine	25	11
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Ozempic	Semaglutide	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Levetiracetam	Levetiracetam	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Pregabalin	Pregabalin	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Depakote Er	Divalproex Sodium	15	suppressed
Diazepam	Diazepam	15	suppressed
Ibu	Ibuprofen	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Torsemide	Torsemide	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Belsomra	Suvorexant	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Naproxen	Naproxen	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error